Results 61 to 70 of about 7,299,987 (302)

Sensitivity, specificity, and distance to (0,1) point of each cut-off point on the HADS.

open access: yes, 2016
Sensitivity, specificity, and distance to (0,1) point of each cut-off point on the HADS.
Andre Tylee (3146625)   +4 more
core   +1 more source

Cut-off times and average number of participants by marathon.

open access: yes, 2023
Differences in cut-off times may be responsible for the variation in the proportion of qualifiers across different marathons. Also, each marathon has different levels of enforcement with cut-off times which could impact the distribution of finishers ...
Ross Ring-Jarvi (15322327)   +2 more
core   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Optimal waist circumference cut-off points for predicting metabolic syndrome among low-income black South African adults

open access: yesBMC Research Notes, 2018
Objective Waist circumference has been identified as one of the strongest predictive tool for metabolic syndrome. This study determines the optimal cut-off point of waist circumference for metabolic syndrome among low-income earning South African black ...
Eyitayo Omolara Owolabi   +3 more
doaj   +1 more source

Cut-off points with sensitivity and specificity.

open access: yes, 2016
Cut-off points with sensitivity and specificity.
Jo-Eun Jeong (2993349)   +8 more
core   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann   +8 more
wiley   +1 more source

Estimation of Validation and Reliability of Screening Test of Tobacco, Alcohol and Addictive Drugs in Iran

open access: yesResearch on Addiction, 2013
Objective: the aim of the present study was the estimation of validation and reliability test of ASSIST instrument in Iran. Method: our research populations were Iranian alcohol and drugs users and abusers in the year 1390 that had referred to ...
zahra Hooshyari   +2 more
doaj  

Cut-off points for remission in HUPI.

open access: yes, 2016
Cut-off points for remission in HUPI.
Ana M. Ortiz (189947)   +6 more
core   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari   +5 more
wiley   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy